Drug recall · June 18, 2025
Levothyroxine Sodium Tablets recall
Why: Presence of a foreign substance: black hair found embedded in tablet.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.
- Lots / codes
Lot #: MLF2401A, Exp 01/31/2026
- Quantity
- 1,344- 1000 count bottles
- Company
- Macleods Pharmaceuticals Ltd, Mumbai
- Distribution
- Nationwide in the USA
- Initiated
- May 29, 2025 · Voluntary: Firm initiated
- Classified
- June 12, 2025
- Reported
- June 18, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levothyroxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.